A living systematic review and meta-analysis characterising treatment regimes, clinical outcomes and complications associated with extracorporeal life support (ELS) for critical COVID-19 in women in pregnancy and the puerperium compared to non-pregnant women of reproductive age and comparing materno-fetal outcomes to pregnant women without COVID-19
Author(s)
Greer, Orene
Type
Other
Abstract
Review question
1. To characterise the prevalence, treatment regimes, clinical outcomes and complications of COVID-19-related extracorporeal life support (ELS) as therapy for women in pregnancy/ puerperium compared to non-pregnant women of reproductive age with COVID-19.
2. To characterise maternal and fetal clinical outcomes for pregnant and puerperal patients with critical COVID-19-managed by ELS compared to pregnant women without COVID-19.
1. To characterise the prevalence, treatment regimes, clinical outcomes and complications of COVID-19-related extracorporeal life support (ELS) as therapy for women in pregnancy/ puerperium compared to non-pregnant women of reproductive age with COVID-19.
2. To characterise maternal and fetal clinical outcomes for pregnant and puerperal patients with critical COVID-19-managed by ELS compared to pregnant women without COVID-19.
Date Issued
2022-01-04
Citation
2022
Copyright Statement
© 2023 The Author(s).
Identifier
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022266537